Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/eabbCfbwoceTmTdVtiQJ

November 16, 2012News for medical technology professionals

  Top Story 
  • Cook gets FDA OK for device to treat peripheral artery disease
    The FDA has granted Cook Medical approval for its Zilver PTX drug-eluting peripheral stent, the first such device to be approved in the U.S. The self-expanding metal stent, which is coated with the paclitaxel drug, is used to reopen blocked or narrowed femoropopliteal arteries in patients with peripheral artery disease. MedCityNews.com (11/15) LinkedInFacebookTwitterEmail this Story
  Business & Market Trends 
  • Texas cancer imaging firm obtains $14.5 million
    A regulatory filing indicated that Seno Medical Technologies has obtained $14.5 million in a round of financing from 28 undisclosed backers. The San Antonio company is working on a device that identifies the location of tumors in breast issue using opto-acoustic imaging. MassDevice.com (Boston) (11/14) LinkedInFacebookTwitterEmail this Story
  • Calif. heart device startup looks to obtain $14M by year's end
    Medical Device Innovations hopes to raise $14 million in a funding round set to close by the end of 2012. The Carlsbad, Calif.-based startup plans to use the money in part to conduct clinical studies of its catheter-based technology that does not depend on any energy source to treat patients with atrial fibrillation. MedCityNews.com (11/14) LinkedInFacebookTwitterEmail this Story
 
  • Funding round brings in almost $3.5 million for iRhythm
    IRhythm Technologies has secured almost $3.5 million in a funding round. The San Francisco startup is the maker of the Zio Patch system, a single-use device that can be worn for a maximum of 14 days to monitor cardiac rhythm continuously in asymptomatic patients. MedCityNews.com (11/15) LinkedInFacebookTwitterEmail this Story
  • Allied Minds backs atrial fibrillation device firm
    Allied Minds, a Boston-based investment group, has provided more than $1 million in funding to help establish LuxCath. The newly formed company is working on a device that can be used to help treat patients with atrial fibrillation by allowing heart lesions to be viewed in real time. Mass High Tech (Boston) (11/15) LinkedInFacebookTwitterEmail this Story
  International Developments 
  • Database aims to foster collaboration among HTA bodies in EU
    EUnetHTA, a health technology assessment network in Europe, has introduced the Evidence Database on New Technologies, or EVIDENT, in an effort to promote more collaboration among HTA agencies in the region. The database is designed to assemble and exchange early information on study gaps as well as additional data requests from HTA entities. Clinica (subscription required) (11/14) LinkedInFacebookTwitterEmail this Story
  Science & Health 
  • Biotronik wins FDA approval for peripheral artery stent trial
    Biotronik has received investigational device exemption approval from the FDA to include U.S. patients in a study of its Pulsar-18 stent, which is targeted at the superficial femoral artery and can be used to treat different sizes of lesions. The company also has completed the first implantation of the self-expanding stent in the U.S. MassDevice.com (Boston) (11/14) LinkedInFacebookTwitterEmail this Story
  Emerging Technologies 
  • Teleflex's vascular access catheter scores 510(k) clearance
    The FDA has cleared Teleflex to market its Nylus catheter, which is delivered peripherally to the central venous system. The device was first cleared in Europe in July and is intended to help minimize the risk of blood clot-related complications during infusions, among other applications. BeckersASC.com (11/15) LinkedInFacebookTwitterEmail this Story
  Government & Regulatory 
  • FDA approves study of Abiomed's right ventricle heart pump
    Abiomed has received investigational device exemption approval from the FDA to conduct a clinical study of its Impella RP device, a new cardiac pump used to access the right ventricle of the heart through the vena cava. The device will be tested for two years in 30 patients with right-side heart failure. MassDevice.com (Boston) (11/15) LinkedInFacebookTwitterEmail this Story
AdvaMed News 
  • Follow AdvaMed on Google+
    Stay updated on industry news and educational opportunities -– receive an intimate understanding of the key issues affecting innovation, access and the bottom line. Network with industry experts and leaders. Our Google+ page is interactive and incorporates updates from key stakeholders, influencers and industry thought leaders as well as regulatory and policy experts from the FDA and CMS. Follow us on Google+. LinkedInFacebookTwitterEmail this Story
 
Learn more about AdvaMed ->About AdvaMed | Join | Courses | Events | Newsroom

 
Position TitleCompany NameLocation
Director of Quality CEA Medical Manufacturing Colorado Springs, CO
Clinical Education Manager, Vascular TherapiesCovidienMansfield, MA
Senior/Principal Mechanical EngineerChannel MedsystemsSan Francisco, CA
Director, Global Labeling - 001592Edwards LifesciencesIrvine, CA
Director, Valve Testing - Transcatheter Heart Valve - 001221Edwards LifesciencesIrvine, CA
Manager, Grassroots and Member Engagement, Government Affairs AdvaMedWashington, DC
Associate Vice President, Global Strategy and Analysis (Asian Region) AdvaMedWashington, DC
Manager, Regulatory Affairs Sequenom, Inc.San Diego, CA
Packaging Engineer/Project LeaderEndologix, Inc.Irvine, CA
Sr. Manager R & D, Systems Integration EngineeringAbbott LaboratoriesSanta Ana, CA
Associate Director, Regulatory AffairsAbbott LaboratoriesSanta Clara, CA
Senior Marketing Communications Manager - Cardiac Surgery Systems - 001558Edwards LifesciencesIrvine, CA
Physician Training Program ManagerEndologix, Inc.Irvine, CA
Director Clinical Research - CapnographyCovidienBoulder, CO
Regulatory Affairs Associate DirectorAbbott LaboratoriesSanta Clara, CA
Compliance Manager, Global DistributionCooperVision, Inc.Rochester, NY or Pleasanton, CA, NY
Field Service Engineer IRIS International, IncSacramento, CA
Quality EngineerIRIS International, IncChatsworth, CA
Medical and Clinical Laboratory TechnologistIRIS International, IncChatsworth, CA
Senior Mechanical EngineerIRIS International, IncChatsworth, CA
Clinical & Customer Care SpecialistIRIS International, IncLos Angeles, CA
Developmental Cell Biologist/BiochemistIRIS International, IncCarlsbad, CA
Principal Systems Engineer IRIS International, IncChatsworth, CA
Field Service Engineer IRIS International, IncProvidence, RI
Director Professional Medical Education CovidienBoulder, CO
REGULATORY AFFAIRS ENGINEERWelch AllynSkaneateles, NY
Senior Director, QualityAmerican Medical SystemsMinneapolis, MN
Click here to view more job listings.

  SmartQuote 
One thing I am convinced more and more is true and that is this: The only way to be truly happy is to make others happy. When you realize that and take advantage of the fact, everything is made perfect."
--William Carlos Williams,
American poet and physician


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Account Director:  Meryl Harold (202) 407-7828
Job Board:  Jackie Basso (202) 407-7871
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent AdvaMed SmartBrief Issues:   Lead Editor:  Lisa Gough
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2012 SmartBrief, Inc.® Legal Information